Skip to main content

. 1962 Jul 21;2(5298):156–158. doi: 10.1136/bmj.2.5298.156

Another Hypotensive Agent—Methyldopa

Denis Daley, Byron Evans

PMCID: PMC1925375 PMID: 13883201

156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DOLLERY C. T., EMSLIE-SMITH D., MILNE M. D. Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet. 1960 Aug 20;2(7147):381–387. doi: 10.1016/s0140-6736(60)92836-1. [DOI] [PubMed] [Google Scholar]
GILLESPIE L., Jr, OATES J. A., CROUT J. R., SJOERDSMA A. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962 Feb;25:281–291. doi: 10.1161/01.cir.25.2.281. [DOI] [PubMed] [Google Scholar]
OATES J. A., GILLESPIE L., UDENFRIEND S., SJOERDSMA A. Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science. 1960 Jun 24;131(3417):1890–1891. doi: 10.1126/science.131.3417.1890. [DOI] [PubMed] [Google Scholar]
SOURKES T. L. Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine. Arch Biochem Biophys. 1954 Aug;51(2):444–456. doi: 10.1016/0003-9861(54)90500-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES